Jinhan Kim, Co-founder and CEO, Standigm Repetitive behavioral disorders such as obsessive-compulsive disorder (OCD), Tic Disorder and Tourette Syndrome have been challenging to… Continue Reading
Articles
Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced… Continue Reading
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
Acquisition to expand endoluminal surgery portfolio and add differentiated technologies for endobariatric procedures MARLBOROUGH, Mass., Nov. 29, 2022 /PRNewswire/ — Boston Scientific Corporation (NYSE:… Continue Reading
Ribon Therapeutics Announces Acquisition of Pre-Clinical CD38 Program by Boehringer Ingelheim
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Ribon Therapeutics, a clinical stage biotechnology company developing therapeutics targeting stress support pathways, today announced that it entered… Continue Reading
Quest Diagnostics Completes Acquisition of Outreach Lab Services Business of Summa Health
Physicians and patients to benefit from access to Quest’s industry-leading test menu and broad health plan relationships in Northeastern Ohio SECAUCUS,… Continue Reading
Roundup: Indian Startups Score New Fundings and More Briefs
Ayurveda tech startup NirogStreet snaps up $12M in Series B funding NirogStreet, an Ayurveda technology platform in India, has scored… Continue Reading
Health Management Platform Novi Health Raises $5M in Series A Funding Round
Novi Health, a Singapore-based health tech company and specialist clinic, has scored $5 million in a Series A funding round… Continue Reading
State AGs urge Apple to Better Protect Reproductive Health Data
In a letter to CEO Tim Cook, ten state attorneys general called on the tech giant to require stricter privacy… Continue Reading
Tiziana Announces Publication of a Peer-Reviewed Article on the Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function and an Induced T Cell Regulatory Response in Human Subjects
Third-party research conducted by leading U.S. academic institutions published in a peer reviewed journal Frontiers in Immunology shows a favorable safety profile… Continue Reading
Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development
Las Vegas, Nevada, Nov. 23, 2022 (GLOBE NEWSWIRE) — Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused… Continue Reading